Preclinical abuse potential assessment of the anticonvulsant zonisamide.
- Published in:
- Drug Development Research, 2001, v. 54, n. 2, p. 66, doi. 10.1002/ddr.1206
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2001 AND VI 54 AND IP 2
Results: 6
1
2
Bioisosterism, enantioselectivity, and molecular modeling of new effective N<sup>6</sup>- and/or N(9)-substituted 2-phenyl adenines and 8-aza analogs: Different binding modes to A<sub>1</sub> adenosine receptors.
- Published in:
- Drug Development Research, 2001, v. 54, n. 2, p. 52, doi. 10.1002/ddr.1205
- By:
- Publication type:
- Article
3
Animal models of the anxiogenic effects of ethanol withdrawal.
- Published in:
- Drug Development Research, 2001, v. 54, n. 2, p. 95, doi. 10.1002/ddr.1209
- By:
- Publication type:
- Article
4
Prophylactic effects of caprine serum factor (CSF-I) in mice infected with Salmonella typhimurium.
- Published in:
- Drug Development Research, 2001, v. 54, n. 2, p. 45, doi. 10.1002/ddr.1204
- By:
- Publication type:
- Article
5
5-HT<sub>2C</sub> receptor antagonists: Potential in schizophrenia.
- Published in:
- Drug Development Research, 2001, v. 54, n. 2, p. 88, doi. 10.1002/ddr.1208
- By:
- Publication type:
- Article
6
Potent P2X<sub>7</sub> receptor antagonists: Tyrosyl derivatives synthesized using a sequential parallel synthetic approach.
- Published in:
- Drug Development Research, 2001, v. 54, n. 2, p. 75, doi. 10.1002/ddr.1207
- By:
- Publication type:
- Article